Abstract
Aims: To evaluate the performance of two matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry platforms to identify molds isolated from clinical specimens. Methods: Fifty mold isolates were analyzed on Bruker Biotyper® and Vitek® MS platforms. Two Bruker Biotyper extraction protocols were assessed alongside the US FDA-approved extraction protocol for Vitek MS. Results: The Bruker Biotyper modified NIH-developed extraction protocol correctly identified more isolates than Bruker’s protocol (56 vs 33%). For species in the manufacturers’ databases, Vitek MS correctly identified 85% of isolates, with 8% misidentifications. The Bruker Biotyper identified 64%, with no misidentifications. For isolates not in the databases, the Bruker Biotyper did not misidentify any, and Vitek MS misidentified 36%. Conclusion: Both the Vitek MS and Bruker Biotyper accurately identified the fungal isolates, however Vitek MS was more likely to misidentify isolates than the Bruker Biotyper.
Plain language summary
There are two different mass spectrometry systems that can be used in the hospital laboratory to find out what kind of mold is growing from a patient sample: the Vitek® MS and Bruker Biotyper® systems. This study compared how well they work for mold identification and also looked at two different ways to prepare the mold for testing. The Vitek MS system identified more molds, but also made more mistakes when identifying them. The Bruker Biotyper identified fewer molds but did not make any mistakes on the identification. The Vitek MS system sometimes gets the type of mold wrong, so more tests may be needed to be sure of the result. The Bruker Biotyper is more accurate because it got all of the molds correct, but it could not identify as many.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . MALDI-TOF mass spectrometry for microorganism identification. Clin. Lab. Med. 33(3), 589–609 (2013).
- 2. . MALDI-TOF MS for the diagnosis of infectious diseases. Clin. Chem. 61(1), 100–111 (2015).
- 3. . Performance of MALDI-TOF MS platforms for fungal identification. Mycoses 59(11), 678–690 (2016). •• Very thoroughly reviews different matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry platforms used in the clinical lab, their preprocessing, processing and interpretation methods and their accuracy.
- 4. . Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J. Clin. Microbiol. 51(3), 828–834 (2013).
- 5. Evaluation of three MALDI-TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada. Mycoses 61(10), 743–753 (2018).
- 6. MALDI-TOF MS-based identification of melanized fungi is faster and reliable after the expansion of in-house database. Proteomics Clin. Appl. 13(3), e1800070 (2019).
- 7. Identification of filamentous fungi isolates by MALDI-TOF mass spectrometry: clinical evaluation of an extended reference spectra library. Med. Mycol. 52(8), 826–834 (2014).
- 8. Assessment of various parameters to improve MALDI-TOF MS reference spectra libraries constructed for the routine identification of filamentous fungi. BMC Microbiol. 13, 76 (2013).
- 9. A side by side comparison of Bruker Biotyper and Vitek MS: utility of MALDI-TOF MS technology for microorganism identification in a public health reference laboratory. PLOS ONE 10(12), e0144878 (2015).
- 10. . Comparison of matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of moulds in the routine microbiology laboratory. Clin. Microbiol. Infect. 25(7), 892–897 (2019).
- 11. Multicenter evaluation of three different MALDI-TOF MS systems for identification of clinically relevant filamentous fungi. Med. Mycol. 59(1), 81–86 (2021).
- 12. Performance evaluation of Bruker Biotyper, ASTA MicroIDSys, and Vitek-MS and three extraction methods for filamentous fungal identification in clinical laboratories. J. Clin. Microbiol. 60(11), e0081222 (2022).
- 13. Interpretive criteria for identification of bacteria and fungi by targeted DNA sequencing (2nd Edition) Clinical and Laboratory Standards Institute, PA, USA (2018).
- 14. . Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system. J. Clin. Microbiol. 37(6), 1846–1851 (1999).
- 15. Bruker. Standard operating procedure: cultivation and sample preparation for filamentous fungi (5032285 Revision E) (2019).
- 16. Multicenter study demonstrates standardization requirements for mold identification by MALDI-TOF MS. Front. Microbiol. 10, 2098 (2019).
- 17. . In: Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems (1st Edition). Clinical and Laboratory Standards Institute, PA, USA (2015).
- 18. . Bruker:Microbiology & Diagnostics. www.bruker.com/en/products-and-solutions/microbiology-and-diagnostics/microbial-identification.html (Accessed 9 June 2023).
- 19. Bruker. Mbt filamentous fungi suite (2022). https://www.bruker.com/en/products-and-solutions/microbiology-and-diagnostics/microbial-identification/mbt-filamentous-fungi-library.html
- 20. Decision criteria for MALDI-TOF MS-based identification of filamentous fungi using commercial and in-house reference databases. BMC Microbiol. 17(1), 25 (2017). • Describes methods to improve identifications on the Bruker Biotyper platform and provides evidence that the 1.7 score threshold should be used for mold identification.
